Current studies demonstrate how COVID-19 vaccines have resulted in robust humoral responses in the pediatric population up to 1 year following immunization, while vaccination against SARS-CoV-2 was linked to a lower recurrence infection rate and showed a trend toward reducing the prevalence of other flu-like illnesses [ 2 , 3 ].
← all excerpts
Lifestyle and Biochemical Parameters That May Hamper Immune Responses in Pediatric Patients After Immunization with the BNT162b2 mRNA COVID-19 Vaccine.
1
—
—